Gondal TA, Chaudhary N, Bajwa H et al (2023) Anal cancer: the past, present and future. Curr Oncol 30:3232–3250. https://doi.org/10.3390/curroncol30030246

Article  PubMed  PubMed Central  Google Scholar 

Nelson VM, Benson AB 3rd (2017) Epidemiology of anal canal cancer. Surg Oncol Clin N Am 26:9–15. https://doi.org/10.1016/j.soc.2016.07.001

Article  PubMed  Google Scholar 

Park IJ, Chang G (2020) Survival and operative outcomes after salvage surgery for recurrent or persistent anal cancer. Ann Coloproctol 36:361–373. https://doi.org/10.3393/ac.2020.12.29

Article  PubMed  PubMed Central  Google Scholar 

Pedersen TB, Gocht-Jensen P, Klein MF (2018) 30-day and long-term outcome following salvage surgery for squamous cell carcinoma of the anus. Eur J Surg Oncol 44:1518–1521. https://doi.org/10.1016/j.ejso.2018.06.016

Article  CAS  PubMed  Google Scholar 

Silva DallaLibera L, Almeida de Carvalho KP, Enocencio Porto Ramos J et al (2019) Human papillomavirus and anal cancer: prevalence, genotype distribution, and prognosis aspects from midwestern region of Brazil. J Oncol 2019:6018269. https://doi.org/10.1155/2019/6018269

Article  CAS  Google Scholar 

Ryan DP, Compton CC, Mayer RJ (2000) Carcinoma of the anal canal. N Engl J Med 342:792–800. https://doi.org/10.1056/NEJM200003163421107

Article  CAS  PubMed  Google Scholar 

Nigro ND, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17:354–356. https://doi.org/10.1007/BF02586980

Article  CAS  PubMed  Google Scholar 

Nigro ND, Seydel HG, Considine B et al (1983) Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 51:1826–1829. https://doi.org/10.1002/1097-0142(19830515)51:10%3c1826:aid-cncr2820511012%3e3.0.co;2-l

Article  CAS  PubMed  Google Scholar 

Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Coordinating Committee on Cancer Research. Lancet 1996; 348:1049–1054. https://doi.org/10.1016/S0140-6736(96)03409-5.

Bartelink H, Roelofsen F, Eschwege F et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040–2049. https://doi.org/10.1200/JCO.1997.15.5.2040

Article  CAS  PubMed  Google Scholar 

Flam M, John M, Pajak TF et al (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14:2527–2539. https://doi.org/10.1200/JCO.1996.14.9.2527

Article  CAS  PubMed  Google Scholar 

Ajani JA, Winter KA, Gunderson LL et al (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299:1914–1921. https://doi.org/10.1001/jama.299.16.1914

Article  CAS  PubMed  Google Scholar 

Gunderson LL, Winter KA, Ajani JA et al (2012) Long-term update of US GI intergroup RTOG 98–11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol 30:4344–43451. https://doi.org/10.1200/JCO.2012.43.8085

Article  CAS  PubMed  PubMed Central  Google Scholar 

Untiedt AS, Rolf D, Scobioala S et al (2023) Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma. Strahlenther Onkol 199:749–760. https://doi.org/10.1007/s00066-023-02056-y

Article  PubMed  PubMed Central  Google Scholar 

Frakulli R, Buwenge M, Cammelli S et al (2018) Brachytherapy boost after chemoradiation in anal cancer: a systematic review. J Contemp Brachytherapy 10:246–253. https://doi.org/10.5114/jcb.2018.76884.30038645

Article  PubMed  PubMed Central  Google Scholar 

Katano A, Yamashita H (2021) Definitive radiotherapy for patients with anal squamous cell carcinoma: a retrospective cohort study. Cureus 13:e18732. https://doi.org/10.7759/cureus.18732

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 71:372. https://doi.org/10.1136/bmj.n71

Article  Google Scholar 

Oehler-Jänne C, Seifert B, Lütolf UM et al (2007) Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma. Brachytherapy 6:218–226. https://doi.org/10.1016/j.brachy.2007.02.152

Article  PubMed  Google Scholar 

Arcelli A, Buwenge M, Macchia G et al (2019) Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: a mono-institutional retrospective analysis. J Contemp Brachytherapy 11:21–27. https://doi.org/10.5114/jcb.2019.82804

Article  PubMed  PubMed Central  Google Scholar 

Kent C, Bessell EM, Scholefield JH et al (2017) Chemoradiotherapy with brachytherapy or electron therapy boost for locally advanced squamous cell carcinoma of the anus-reducing the colostomy rate. J Gastrointest Cancer 48:1–7. https://doi.org/10.1007/s12029-016-9850-4

Article  CAS  PubMed  Google Scholar 

Moureau-Zabotto L, Ortholan C, Hannoun-Levi JM et al (2013) Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study). Int J Radiat Oncol Biol Phys 85:e135-142. https://doi.org/10.1016/j.ijrobp.2012.09.034

Article  PubMed  Google Scholar 

Allal AS, Mermillod B, Roth AD et al (1997) The impact of treatment factors on local control in T2–T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer 79:2329–2335. https://doi.org/10.1002/(sici)1097-0142(19970615). (PMID: 9191520)

Article  CAS  PubMed  Google Scholar 

Mazeron J, Scalliet P, Van Limbergen E et al (2002). Radiobiology of brachytherapy and the dose-rate effect. The GEC ESTRO handbook of brachytherapy 96–121.

ICRU Report 50. International Commission on Radiation Units and Measurements; Washington, DC: 1993. Prescribing, recording and reporting photon beam therapy.

ICRU Report 62. International Commission on Radiation Units and Measurements; Bethesda, MD: 1999. Prescribing, recording, and reporting photon beam therapy (supplement to ICRU report 50).

ICRU Report 83. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT) J ICRU 2010;10(1).

Armpilia C, Dale RG, Sandilos P et al (2006) Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy. Phys Med Biol 51:4399–4411. https://doi.org/10.1088/0031-9155/51/17/018

Article  CAS  PubMed  Google Scholar 

Tornero-Lopez AM, Guirado D (2018) Radiobiological considerations in combining doses from external beam radiotherapy and brachytherapy for cervical cancer. Rep Pract Oncol Radiother 23:562–573. https://doi.org/10.1016/j.rpor.2018.05.007

Article  PubMed  PubMed Central  Google Scholar 

Weber DC, Kurtz JM, Allal AS (2001) The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 50:675–680. https://doi.org/10.1016/s0360-3016(01)01510-3

Article  CAS  PubMed  Google Scholar 

Keane J, Fyles A, O’Sullivan B et al (1992) The effect of treatment duration on local control of squamous carcinoma of the tonsil and carcinoma of the cervix. Seminars in Radiation Oncology 2:26–28. https://doi.org/10.1016/S1053-4296(05)80047-5

Article  Google Scholar 

Varela Cagetti L, Moureau-Zabotto L, Zemmour C et al (2023) The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatments. Brachytherapy 22:531–541. https://doi.org/10.1016/j.brachy.2023.03.004

Article  PubMed  Google Scholar 

Doniec JM, Schniewind B, Kovács G et al (2006) Multimodal therapy of anal cancer added by new endosonographic-guided brachytherapy. Surg Endosc 20:673–678. https://doi.org/10.1007/s00464-004-2287-z

Article  CAS  PubMed  Google Scholar 

Vordermark D, Flentje M, Sailer M et al (2001) Intracavitary afterloading boost in anal canal carcinoma. Results, function and quality of life. Strahlenther Onkol 177:252–258. https://doi.org/10.1007/pl00002405